New drug duo aims to tackle Transplant-Related lymphoma
Disease control
Recruiting now
This study tests whether combining two antibody drugs, tafasitamab and rituximab, can effectively treat a type of lymphoma that sometimes occurs after an organ transplant. About 28 adults who have developed this condition will receive the drug combination. The main goal is to see…
Phase: PHASE2 • Sponsor: Timothy Voorhees • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC